Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
186.25    1.15 (0.62%)
Bid:
186.25
Ask:
186.35
Spread: 0.10 (0.054%)
Market Cap: £8.44b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Director Declaration

19 Nov 2025 11:05

RNS Number : 1973I
Centrica PLC
19 November 2025
 

19 November 2025

Centrica plc

('Centrica' or 'the Company')

Director Declaration

In accordance with UK Listing Rule 6.4.9, Centrica notes that Jupiter Fund Management plc ('Jupiter') has today announced that Nathan Bostock, Non-Executive Director and Chair of the Audit and Risk Committee of Centrica, has been appointed as a non-executive director and Chair designate of Jupiter with effect from 1 March 2026 and will take on the role of Chair of Jupiter, subject to regulatory approval, with effect from 1 April 2026.Nathan will continue to serve on the Centrica Board and as Chair of the Audit and Risk Committee until no later than the end of July 2026 (subject to re-election at Centrica's 2026 Annual General Meeting). A further update on his successor will be provided in due course. In the meantime, Nathan's current responsibilities with Centrica remain unchanged. There are no other matters requiring disclosure under UK Listing Rule 6.4.6 or 6.4.9.

 

Enquiries:

Investors and AnalystsE: ir@centrica.com

MediaT: 01784 843000E: media@centrica.com

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNPKCBPKBDDPDD
Date   Source Headline
14th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20234:45 pmRNSHolding(s) in Company
12th Apr 20236:25 pmRNSTransaction in Own Shares
12th Apr 20235:00 pmRNSHolding(s) in Company
12th Apr 20232:45 pmRNSDirector/PDMR Shareholding
11th Apr 20236:25 pmRNSTransaction in Own Shares
6th Apr 20236:30 pmRNSTransaction in Own Shares
6th Apr 20234:30 pmRNSHolding(s) in Company
5th Apr 20236:30 pmRNSTransaction in Own Shares
5th Apr 20232:15 pmRNSHolding(s) in Company
5th Apr 20232:00 pmRNSTransfer of Treasury Shares
5th Apr 20237:00 amRNSCommencement of Share Buy-Back Programme
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20235:30 pmRNSDirector/PDMR Shareholding
29th Mar 20236:25 pmRNSTransaction in Own Shares
28th Mar 20236:25 pmRNSTransaction in Own Shares
27th Mar 20236:20 pmRNSTransaction in Own Shares
27th Mar 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 20236:15 pmRNSTransaction in Own Shares
24th Mar 20235:00 pmRNSHolding(s) in Company
24th Mar 202310:00 amRNSHolding(s) in Company
23rd Mar 20236:00 pmRNSTransaction in Own Shares
22nd Mar 20236:10 pmRNSTransaction in Own Shares
22nd Mar 20233:30 pmRNSDirector/PDMR Shareholding
22nd Mar 202311:19 amRNSAnnual Financial Report 2022
21st Mar 20236:10 pmRNSTransaction in Own Shares
20th Mar 20236:20 pmRNSTransaction in Own Shares
20th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20236:15 pmRNSTransaction in Own Shares
16th Mar 20236:00 pmRNSTransaction in Own Shares
16th Mar 20235:00 pmRNSHolding(s) in Company
15th Mar 20236:25 pmRNSTransaction in Own Shares
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20239:00 amRNSDirector/PDMR Shareholding
14th Mar 20236:20 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSPlans to extend life of two nuclear power stations
13th Mar 20236:25 pmRNSTransaction in Own Shares
13th Mar 20232:00 pmRNSDirector/PDMR Shareholding
10th Mar 20236:15 pmRNSTransaction in Own Shares
10th Mar 20233:45 pmRNSHolding(s) in Company
9th Mar 20236:15 pmRNSTransaction in Own Shares
8th Mar 20236:25 pmRNSTransaction in Own Shares
7th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20234:20 pmRNSHolding(s) in Company
6th Mar 202312:50 pmRNSHolding(s) in Company
3rd Mar 20236:25 pmRNSTransaction in Own Shares
2nd Mar 20236:25 pmRNSTransaction in Own Shares
2nd Mar 20233:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.